Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989 Jul;84(1):162-72.
doi: 10.1172/JCI114136.

Anti-KJ: a new antibody associated with the syndrome of polymyositis and interstitial lung disease

Affiliations

Anti-KJ: a new antibody associated with the syndrome of polymyositis and interstitial lung disease

I N Targoff et al. J Clin Invest. 1989 Jul.

Abstract

Antibodies to aminoacyl-tRNA synthetases (anti-Jo-1, anti-PL-7, anti-PL-12) have been found in the serum of some patients with polymyositis (PM). Patients with these antibodies have an unusually high rate of interstitial lung disease (ILD) in association with their PM. Two patients (K.J. and B.T.) with severe ILD and PM were found to have antibodies to a cytoplasmic antigen, but tests to determine whether the antigen was an aminoacyl-tRNA synthetase were negative, including tests of KJ serum for inhibitory effects on the 20 synthetases. KJ immunoprecipitates did not contain tRNA, in contrast to antisynthetase sera. When IgG samples were added to a reticulocyte in vitro translation system at a concentration of 0.3 mg/ml, KJ IgG inhibited globin mRNA translation by 98%, while anti-Jo-1 IgG inhibited 62% and normal IgG had little effect. Thus, both anti-KJ and the antisynthetases are directed at antigens that are involved in translation and protein synthesis, and both are associated with the syndrome of lung disease and PM. This syndrome may be associated with antibodies to translation-related proteins in general, which may have implications for the link of PM and enteroviruses, which are mRNA viruses.

PubMed Disclaimer

References

    1. Methods Enzymol. 1983;96:50-74 - PubMed
    1. Clin Dermatol. 1988 Apr-Jun;6(2):76-92 - PubMed
    1. J Clin Immunol. 1984 Jan;4(1):40-4 - PubMed
    1. Am J Med. 1984 Mar;76(3):538-44 - PubMed
    1. Biochem Biophys Res Commun. 1984 Apr 16;120(1):15-21 - PubMed

Publication types